HOME >> MEDICINE >> NEWS
Accountability in Clinical Research: Balancing Risk and Benefit

INDIANAPOLIS - Human participation in research has surged in recent years as scientists seek causes and cures of myriad diseases. Accompanying the increase too has been greater public concern for patient safety and scrutiny of complex ethical, legal and regulatory issues.

Such issues will be tackled April 24-26 by Indiana University School of Medicine physicians and researchers and other prominent scientists at a national forum at the University Place Conference Center on the Indiana University-Purdue University Indianapolis campus. Accountability in Clinical Research: Balancing Risk and Benefit, sponsored by the National Patient Safety Foundation, will examine the management, conduct, funding and accountability of research involving human subjects.

Sharon M. Moe, M.D., IU School of Medicine's assistant dean for research support, will lead talks in a session about the role of oversight in assuring patient safety in clinical research. Eric M. Meslin, Ph.D., director of the IU Center for Bioethics, takes the lead in discussing the quality and content of information supplied to research patients about their roles and risks Media interest in biomedical research also has sharply increased, often focusing on controversial incidents involving health outcomes of patients. David W. Crabb, M.D., chairman of the School's Department of Medicine, and members of Indianapolis' news media will discuss and analyze real and hypothetical situations and responses to media coverage.

"This conference opens the door to continued dialogue about patient safety issues in clinical research settings," says Carol A. Ley, M.D., Ph.D., chair of NPSF's board of directors.

"The insight and experiences shared at this conference will be invaluable to health-care professionals, researchers, consumers and government entities - all essential in moving patient safety messages to a new level."

Today's health care consumers, payers, providers and profess
'"/>

Contact: Joe Stuteville
jstutevi@iupui.edu
317-274-7722
Indiana University
10-Apr-2002


Page: 1 2

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical research key in advance to prospective health care
7. Clinical trial of new TB vaccine begins
8. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
9. Clinical factors useful to identify heart failure patients with high risk of death
10. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
11. $7 million grant continues Asthma Clinical Research Network efforts

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Accountability Clinical Research Balancing Risk and Benefit

(Date:3/29/2015)... At the 2015 International Health Racquet ... introduced the new Fonda wall mounted heater and a ... owners and facilities managers with saunas smaller than 425 ... of the Fonda heater. With an attractive seamless ... immediate upgrade for a sauna, especially when mounted in ...
(Date:3/29/2015)... 2015 Pro Ace Care Heating & ... now provide qualified HVAC technicians that will visit the ... and related systems throughout Vancouver, North Vancouver, Burnaby, Richmond, ... conditioners, heat pumps require regular maintenance from a professional. ... BC Hydro strongly suggest you have it serviced annually ...
(Date:3/29/2015)... Calif. (PRWEB) March 30, 2015 Over ... menopause-related symptoms tied to undiagnosed autoimmune, thyroid, or hormone ... thyroid disorders, has personally treated hundreds of patients dealing ... are unaware of the treatment options for their ailments. ... offers solutions to women living with fatigue, brain fog, ...
(Date:3/29/2015)... 2015 Elfster.com, the top-rated Secret Santa ... promotional plans to publicize its gift exchange generator technology ... Known as the leader in Secret Santa online gift ... adjacent markets can see the opportunities as well. , ... explained Peter Imburg, CEO of Elster.com. "With Christmas and ...
(Date:3/29/2015)... Orion, Clarkston, Metamora, MI. (PRWEB) March 29, 2015 ... Beaumont Hospital, offers comprehensive menopause treatment. Secondary to ... that area a closer hospital option. They continue ... and McLaren Oakland. , Menopause is a ... The term "menopause" can describe any of the changes ...
Breaking Medicine News(10 mins):Health News:Helo Commercial Introduces Fonda Sauna Heater and Sauna and Steam Continuing Education Program at IHRSA 2Health News:Pro Ace Care Now Provides Qualified HVAC Technicians for Heat Pump Maintenance 2Health News:How to Turn Mid-life into the Good Life 2Health News:Gift Exchange Generator Promotion Achieves Early Success, Announces Elfster 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2
(Date:3/29/2015)...  Three-month paliperidone palmitate, an investigational atypical antipsychotic, ... in patients with schizophrenia, according to a new ... the Journal of the American Medical ... of the study served as the basis for ... three-month paliperidone palmitate injection to treat schizophrenia in ...
(Date:3/27/2015)... BioCorRx, Inc. ( BICX ) ... a healthcare solutions organization, which focuses solely on addiction treatment; ... the U.S. alone. The Company created a unique treatment program ... compounded form for outpatient surgical implantation. The Company has exclusive ... New Zealand ) to the specially formulated Naltrexone implant. ...
(Date:3/27/2015)... CHAPEL HILL, N.C. , March 27, 2015 /PRNewswire/ ... function is essential to meeting challenges in clinical development, ... and face tighter regulations, the Medical Affairs function is ... charted by mature markets. According to ... market study participants have a group dedicated to Medical ...
Breaking Medicine Technology:New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2Medical Affairs Capabilities Expanding in Emerging Marketplaces 2
Cached News: